Clinical and human experimental pain studies often include so-called “healthy” controls in
investigations of sensory abnormalities, using quantitative sensory testing (QST) as an …

Neuropathic pain is accompanied by both positive and negative sensory signs. To explore
the spectrum of sensory abnormalities, 1236 patients with a clinical diagnosis of neuropathic …

Quantification of the human painful sensory experience is an essential step in the translation
of knowledge from animal nociception to human pain. Translational models for assessment …

Sensitization of the nervous system can present as pain hypersensitivity that may contribute
to clinical pain. In spinal pain, however, the relationship between sensory hypersensitivity …

This is a revision of guidelines, originally published in 2004, for the assessment of patients
with neuropathic pain. Neuropathic pain is defined as pain arising as a direct consequence …

It is evident that chronic pain can modify the excitability of central nervous system which
imposes a specific challenge for the management and for the development of new …

The role of quantitative sensory testing (QST) in prediction of analgesic effect in humans is
scarcely investigated. This updated review assesses the effectiveness in predicting …

We have compiled a comprehensive QST protocol as part of the German Research Network
on Neuropathic Pain (DFNS) using well established tests for nearly all aspects of …

Age-and gender-matched reference values are essential for the clinical use of quantitative
sensory testing (QST). To extend the standard test sites for QST—according to the German …

Hypersensitivity due to central pain mechanisms can influence recovery and lead to worse
clinical outcomes, but the ability of quantitative sensory testing (QST), an index of …